Evolus Inc (EOLS) earnings · rev $297.2M
These earnings events as JSON? API free 100/dayEvolus Inc (EOLS) is a drug manufacturers - specialty & generic company listed on US.
This EOLS earnings page is the cached print — revenue, income, and the latest exhibit — not a live call transcript.
Latest reported EOLS revenue for 2025-12-31 was $297.2M. Net income was -$51.6M. Revenue was up 11.6% from 2024-12-31 to 2025-12-31. EOLS currently screens at market cap $597.0M.
When the next EOLS 8-K Item 2.02 lands, this page should move. Until then the SEC archive is the source.
The change that matters: Revenue was up 11.6% from 2024-12-31 to 2025-12-31. An earnings headline that ignores that move is noise.
Not investment advice. Full EOLS research stays on the stock page; the tape stays on the quote page.
EOLS earnings FAQ
What are EOLS's latest revenue and net income?
Latest cached Evolus Inc (EOLS) revenue for Dec 31, 2025 was $297.2M. Net income was -$51.6M. Statements: https://lician.com/financials/eols
What is EOLS's latest diluted EPS?
Latest cached Evolus Inc (EOLS) diluted EPS for Dec 31, 2025 was -$0.80.
What period does the latest EOLS earnings print cover?
The latest cached Evolus Inc (EOLS) earnings print covers Dec 31, 2025. The prior cached period on this page is Dec 31, 2024.
How did EOLS revenue change from the prior cached period?
Cached Evolus Inc (EOLS) revenue was up 11.6% from $266.3M (Dec 31, 2024) to $297.2M (Dec 31, 2025). Statements: https://lician.com/financials/eols
Where are EOLS earnings listed?
Cached earnings facts for Evolus Inc (EOLS) are listed at https://lician.com/earnings/eols. Statements: https://lician.com/financials/eols
Not investment advice.